Lithotripsy Market Size and Forecast (2021-2031)
Lithotripsy Market Size and Forecast (2021 – 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Extracorporeal Shock Wave Lithotripsy Devices and Intracorporeal Lithotripsy Devices, and Ureteroscopic), Application (Kidney Stones, Ureteral Stones, Pancreatic Stones, Bile Duct Stones, and Bladder Stones), End User (Hospitals, Specialty Clinics, and Others), and Geography
$4,152 – $7,352
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Growth Drivers:
Launch of Innovative Lithotripsy Devices
Several manufacturers are developing technologically advanced products used during lithotripsy to remain competitive in the market across the globe. For example, Boston Scientific developed the Lumenis Pulse 120H Holmium Laser System with MOSES 2.0 Technology. The product technology is capable of treating different stone compositions that utilize several scientific techniques such as stone dusting, popcorning, and fragmentation. Furthermore, it remarkably improves energy transmission, resulting in more efficient lithotripsy treatment compared to regular holmium pulse lithotripsy devices. Also, in Benign Prostatic Hyperplasia (BPH) treatment, MOSES technology results in reducing treatment time by improving enucleation efficiency and hemostasis compared to regular holmium pulse devices. Similarly, in January 2022, Olympus announced the launch of its next-generation SOLTIVE Premium SuperPulsed Laser System (SOLTIVE Laser System). The product offers the potential for short procedure time, better patient outcomes, and low procedure cost as compared to standard Holmium: YAG lithotripsy device. Therefore, the launch of innovative lithotripsy devices drives the market.
Therefore, launching of innovative lithotripsy device is an influential factor responsible for market growth.
Report Segmentation and Scope:
• Based on product type, the lithotripsy market is bifurcated into extracorporeal shock wave lithotripsy devices and intracorporeal lithotripsy devices, and ureteroscopic. The extracorporeal shock wave lithotripsy devices segment held a larger market share in 2023.
• By application, the market is segmented into kidney stones, ureteral stones, pancreatic stones, bile duct stones, and bladder stones. The kidney stones segment held the largest share of the market in 2023.
• By end user, the market is segmented into hospitals, specialty clinics, and others. The hospitals segment dominated the market in 2023.
Type-Based Insights
By type, the lithotripsy market is bifurcated into extracorporeal shock wave lithotripsy devices and intracorporeal lithotripsy devices, and ureteroscopic. The extracorporeal shock wave lithotripsy devices segment held the largest market share of the lithotripsy market in 2023. Extracorporeal Shockwave Lithotripsy (ESWL) is a noninvasive technique that breaks down stones in the urinary system, pancreas, and bile duct. ESWL is one of the most commonly used methods for kidney stones and noninvasive treatment. Also, the recurrence cases of renal stones after ESWL treatment is significantly low. According to a clinical study published in the American Journal of Roentgenology, 104 (70%) of the 148 patients who underwent ESWL at the University of Florida were evaluated to check recurrent renal stone disease after the treatment. The clinical results obtained by the radiography stated that, after ESWL, new stone formation occurs only at a rate of 5% and is much lower than the expected recurrence rate of 37–50% (which is the standard percentage).
Regional Analysis:
The geographic scope of the lithotripsy market report is mainly segmented into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America. Global and regional market analysis covering key market trends, major players, regulations, and recent market developments.
North America has dominated the market. Further, Asia Pacific is anticipated to record the highest CAGR in the coming years. In North America, the US accounted for the largest share of the lithotripsy market in 2023. According to the Korean Urological Association report, the prevalence of nephrolithiasis (kidney stone) is significantly high in the US. The BD company website reveals that kidney stones affect 1 in 11 people in the US annually, causing a considerable healthcare burden and high cost of treatment. The length of time from diagnosis to treatment takes approximately 18 days, with ~50% of the patients recommended to perform lithotripsy procedures [the majority are treated with extracorporeal shockwave lithotripsy (ESWL)] by physicians. Additionally, the most commonly recommended noninvasive procedure in the US is lithotripsy. The NewChoiceHealth.com website reveals that the average cost of lithotripsy in the US accounts for approximately US$ 12,800. In addition, as the lithotripsy procedure is an outpatient treatment for kidney stone removal, the prices might vary. The following table represents the Virginia State lithotripsy (outpatient cost vs licensed ambulatory surgical center cost) recorded in 2018.
Virginia State Hospital Outpatient (US$) Licensed Ambulatory Surgical Center (US$)
Central 8,710 5,385
Eastern 6,273 4,547
Northern 9,796 5,898
Northwestern 9,983 7,133
Southwestern 9,435 NA
Source: Virginia Health Information
Patients undergoing lithotripsy noninvasive procedures can apply for medical reimbursement/coverage in the US, which benefits patients and leads to more lithotripsy procedures (in terms of volume). The New York Urology Specialists report website states that kidney stone treatment in the US is covered under health insurance. The insurance benefits the patients in blood testing, urologist (consultation fees), surgical cost of any chosen noninvasive as well as surgical procedure [lithotripsy, ureteroscopy, or percutaneous nephrolithotomy (PCNL), diagnostic imaging cost, and others]. Therefore, with rising incidences of kidney stones among the US population, demand for lithotripsy devices is also increasing, which boosts the volume of procedures in hospitals and specialized centers due to medical reimbursement/coverage benefits. Therefore, high prevalence of nephrolithiasis accelerates the demand for lithotripsy devices is a key factor influencing the lithotripsy market growth.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
Market Opportunity
Rise in Mobile Lithotripsy Services
Mobile lithotripsy medical units, commercial tractor-trailers, and coaches are significantly beneficial to patients. These units offer patients a new healthcare service without any requirement to set up a specialized lithotripsy center or additional investment. Patients’ experience with mobile lithotripsy services is significantly improving with technological advancements. For example, in June 2021, Mobile Medical announced launching its new state-of-the-art mobile lithotripsy unit. The lithotripter device was successfully removed from the existing lithotripsy center and installed in a cab/mobile truck. Similarly, The Oklahoma Mobile Lithotripsy Associates (OMLA), a subsidiary of Oklahoma Lithotripter Associates, has continued to provide extracorporeal shockwave lithotripsy (ESWL) services to area hospitals through a lithotripsy bus/trailer since 1995. The service began with a single Dornier unit. However, with a rise in technological advancements, the units are now transported to each location in small vans, making accessibility and scheduling noninvasive lithotripsy procedures much more accessible. Currently, mobile lithotripsy service is only available in developed countries, particularly in the US, and is anticipated to grow in other countries in the future if awareness about mobile lithotripsy service is increased worldwide. Thus, the rise in mobile lithotripsy services is anticipated to create lucrative opportunities for the lithotripsy service providers in the market in the coming years.
Future Trend
Preference for Lithotripsy Technique in Coronary Lesion Treatment
Traditionally, lithotripsy is the most recommended noninvasive procedure for kidney stone removal. However, manufacturers are studying lithotripsy medical devices that can be utilized for several other healthcare applications, including the treatment of coronary lesions. With the rise in the aging population, there is a high risk of patients suffering from coronary lesions. Currently, several challenges are associated with coronary intervention, including dissections/incisions. Also, only a few methods are available to manage calcified coronary lesions, including interventional balloons and rotational atherectomy. Furthermore, incisions and incorporating balloons do not remove calcium deposits as they only improve vessel compliance by creating incisions. Such uncontrolled incisions can lead to a high risk of vessel perforation and increased chances of myocardial infarction among patients undergoing cardiac surgery. The new technology of shockwave lithotripsy is set to revolutionize disease treatment through the proper management of severely calcified coronary lesions. In February 2021, the FDA announced approval for a shockwave intravascular lithotripsy (IVL) system for the treatment of severely calcified coronary artery plaques. For example, Shockwave Medical Inc.’s SHOCKWAVE IVL removes coronary lesions by reducing the risk of complications and making the procedure safe and efficient. Thus, preference for the lithotripsy technique in coronary lesion treatment is anticipated to fuel the lithotripsy market growth in the coming years.
Report Segmentation and Scope:
Key segments that contributed to the derivation of the lithotripsy market analysis are product type, application, and end user.
• Based on product type, the lithotripsy market is divided into extracorporeal shock wave lithotripsy devices and intracorporeal lithotripsy devices, and ureteroscopic. The extracorporeal shock wave lithotripsy devices segment held a larger market share in 2023.
• By application, the market is segmented into kidney stones, ureteral stones, pancreatic stones, bile duct stones, and bladder stones. The kidney stones segment held the largest share of the market in 2023.
• In terms of end user, the market is categorized into hospitals, specialty clinics, and others. The hospitals segment dominated the market in 2023.
Edap Tms SA, Becton Dickinson and Co, Olympus Corp, Cook Medical Holdings LLC, Boston Scientific Corp, Karl Storz SE & Co KG, DirexGroup, Dornier MedTech, ELMED Medical Systems, EMS+, NOVAmedtek, and Potent Medical are among the key companies operating in the lithotripsy market. Leading players adopt strategies such as launching new products, expanding and diversifying their market presence, and expanding new customer base to tap prevailing business opportunities.
Industry Developments and Future Opportunities:
Various strategic developments by leading players operating in the lithotripsy market are listed below:
• Shockwave Medical, Inc. announced new product launch “Shockwave L6 Peripheral IVL Catheter” clearance by the US Food and Drug Administration (USFDA). The new product is an advanced product with functionalities such as compact emitter configuration, in conjunction with the four new device sizes (8.0, 9.0, 10.0, and 12.0 millimeter diameters), that enables effective delivery of sonic pressure waves in large vessels. (Source: Shockwave Medical, Inc Company Website, March 2023).
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the global lithotripsy market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TABLE OF CONTENTS<div class="twocol"
LIST OF TABLES<div class="twocol"
LIST OF FIGURES
Figure 1. Lithotripsy Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Lithotripsy Market Revenue (US$ Million), 2021–2031
Figure 5. Lithotripsy Market Revenue (US$ Millions) Forecast Analysis, 2021–2031
Figure 6. Lithotripsy Market Share (%) – by Type (2023 and 2031)
Figure 7. Extracorporeal Shock Have Lithotripsy Devices: Lithotripsy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Intracorporeal Lithotripsy Devices: Lithotripsy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 9. Ureteroscopic: Lithotripsy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 10. Lithotripsy Market Share (%) – by Intracorporeal Lithotripsy Devices By Indications (2023 and 2031)
Figure 11. PCNL: Lithotripsy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 12. Others: Lithotripsy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 13. Lithotripsy Market Share (%) – by PCNL Devices Type (2023 and 2031)
Figure 14. Laser: Lithotripsy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 15. Ultrasonic and Combination: Lithotripsy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 16. Lithotripsy Market Share (%) – by PCNL Devices By Laser Component (2023 and 2031)
Figure 17. Capital: Lithotripsy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 18. Consumables: Lithotripsy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 19. Lithotripsy Market Share (%) – by PCNL Devices By Ultrasonic And Combination Component (2023 and 2031)
Figure 20. Capital: Lithotripsy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 21. Consumables: Lithotripsy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 22. Lithotripsy Market Share (%) – by Ureteroscopy Technique (2023 and 2031)
Figure 23. Ureteroscopy Laser: Lithotripsy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 24. Ureteroscopy Pneumatic Ballistic: Lithotripsy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 25. Lithotripsy Market Share (%) – by Ureteroscopy Laser By Component (2023 and 2031)
Figure 26. Capital: Lithotripsy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 27. Fibre: Lithotripsy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 28. Lithotripsy Market Share (%) – by Ureteroscopy Laser By Type (2023 and 2031)
Figure 29. Thulium: Lithotripsy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 30. High power Holmium: Lithotripsy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 31. Low Power: Lithotripsy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 32. Other Laser: Lithotripsy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 33. Lithotripsy Market Share (%) – by Ureteroscopy Pneumatic Ballistic By Component (2023 and 2031)
Figure 34. Capital: Lithotripsy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 35. Consumables: Lithotripsy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 36. Lithotripsy Market Share (%) – by Application (2023 and 2031)
Figure 37. Kidney Stones: Lithotripsy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 38. Ureteral Stones: Lithotripsy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 39. Pancreatic Stones: Lithotripsy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 40. Bile Duct Stones: Lithotripsy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 41. Bladder Stones: Lithotripsy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 42. Lithotripsy Market Share (%) – by Bladder Stones Technique Type (2023 and 2031)
Figure 43. Laser: Lithotripsy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 44. Mechanical: Lithotripsy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 45. Pneumatic/Ballistic: Lithotripsy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 46. Ultrasonic: Lithotripsy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 47. Lithotripsy Market Share (%) – by End-user (2023 and 2031)
Figure 48. Hospitals: Lithotripsy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 49. Specialty Clinics and Centres: Lithotripsy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 50. Other End Users: Lithotripsy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 51. Lithotripsy Market Breakdown by Region, 2023 and 2031 (%)
Figure 52. North America: Lithotripsy Market – Revenue and Forecast to 2031(US$ Million)
Figure 53. North America: Lithotripsy Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 54. United States: Lithotripsy Market – Revenue and Forecast to 2031(US$ Million)
Figure 55. Canada: Lithotripsy Market – Revenue and Forecast to 2031(US$ Million)
Figure 56. Mexico: Lithotripsy Market – Revenue and Forecast to 2031(US$ Million)
Figure 57. Europe: Lithotripsy Market – Revenue and Forecast to 2031(US$ Million)
Figure 58. Europe: Lithotripsy Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 59. United Kingdom: Lithotripsy Market – Revenue and Forecast to 2031(US$ Million)
Figure 60. Germany: Lithotripsy Market – Revenue and Forecast to 2031(US$ Million)
Figure 61. France: Lithotripsy Market – Revenue and Forecast to 2031(US$ Million)
Figure 62. Spain: Lithotripsy Market – Revenue and Forecast to 2031(US$ Million)
Figure 63. Italy: Lithotripsy Market – Revenue and Forecast to 2031(US$ Million)
Figure 64. Rest of Europe: Lithotripsy Market – Revenue and Forecast to 2031(US$ Million)
Figure 65. Asia Pacific: Lithotripsy Market – Revenue and Forecast to 2031(US$ Million)
Figure 66. Asia Pacific: Lithotripsy Market Breakdown, by PCNL Devices By Laser Component (2023 and 2031)
Figure 67. Asia Pacific: Lithotripsy Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 68. China: Lithotripsy Market – Revenue and Forecast to 2031(US$ Million)
Figure 69. Japan: Lithotripsy Market – Revenue and Forecast to 2031(US$ Million)
Figure 70. India: Lithotripsy Market – Revenue and Forecast to 2031(US$ Million)
Figure 71. Australia: Lithotripsy Market – Revenue and Forecast to 2031(US$ Million)
Figure 72. South Korea: Lithotripsy Market – Revenue and Forecast to 2031(US$ Million)
Figure 73. Rest of APAC: Lithotripsy Market – Revenue and Forecast to 2031(US$ Million)
Figure 74. Middle East and Africa: Lithotripsy Market – Revenue and Forecast to 2031(US$ Million)
Figure 75. Middle East and Africa: Lithotripsy Market Breakdown, by Ureteroscopy Pneumatic Ballistic By Component (2023 and 2031)
Figure 76. Middle East and Africa: Lithotripsy Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 77. Saudi Arabia: Lithotripsy Market – Revenue and Forecast to 2031(US$ Million)
Figure 78. South Africa: Lithotripsy Market – Revenue and Forecast to 2031(US$ Million)
Figure 79. United Arab Emirates: Lithotripsy Market – Revenue and Forecast to 2031(US$ Million)
Figure 80. Rest of Middle East and Africa: Lithotripsy Market – Revenue and Forecast to 2031(US$ Million)
Figure 81. South and Central America: Lithotripsy Market – Revenue and Forecast to 2031(US$ Million)
Figure 82. South and Central America: Lithotripsy Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 83. Brazil: Lithotripsy Market – Revenue and Forecast to 2031(US$ Million)
Figure 84. Argentina: Lithotripsy Market – Revenue and Forecast to 2031(US$ Million)
Figure 85. Rest of South and Central America: Lithotripsy Market – Revenue and Forecast to 2031(US$ Million)
Figure 86. Growth Strategies in the Global Lithotripsy Market
The List of Report Companies – Lithotripsy Market
o Edap Tms SA
o Becton Dickinson and C
o Olympus Corp
o Cook Medical Holdings LLC
o Boston Scientific Corp
o Karl Storz SE & Co KG
o DirexGroup
o Dornier MedTech
o ELMED Medical Systems
o EMS+
o NOVAmedtek
o Potent Medical
You must be logged in to post a review.
Reviews
There are no reviews yet.